mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.08 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.08 |